ZHZhuo Huang

Zhuo Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhuo Huang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reference Genome Choice Shapes RNA-Seq Quantification and Downstream Interpretation in Chinese Breast Cancer Patients

    by Ruiyang Zhang, Yuan Peng, Mengmeng Zhang, Yanan Chu, Changjun Shao, Zhuo Huang, Yiji Yang, Jing Chen, Yu Kang, Shu Wang

    Background/Objectives: Reference genome choice can introduce systematic bias into cancer transcriptomic analyses, particularly for populations underrepresented in standard references. However, its impact on downstream biological interpretation remains insufficiently characterized. Methods: We compared GRCh38, T2T-CHM13, and the East Asian-matched T2T-YAO using bulk RNA-seq data from 148 Chinese breast cancer patients and single-cell RNA-seq data comprising 65,968 cells from paired primary tumors and lymph node metastases. We assessed reference-dependent differences in read mapping, gene expression, and downstream transcriptomic analyses. Results: Compared with GRCh38, YAO reduced multi-mapped reads approximately three-fold and increased confidently exon-assigned reads. Re-mapping YAO-assigned reads to GRCh38 showed that 19.91% changed gene assignment, with a mean of 1016 genes per sample exhibiting more than ten-fold expression differences. Across the cohort, 8432 genes showed such discrepancies, and 68.49% overlapped low-mappability regions in YAO. These genes were enriched in receptor, ion channel, and drug metabolism functions. Reference-dependent expression differences propagated to differential expression, immune cell inference, fusion detection, and classifier performance. In single-cell analyses, T2T references retained more cells after quality filtering and resolved a fibroblast subpopulation missed by GRCh38. Conclusions: Reference genome selection substantially influences RNA-seq quantification and downstream biological interpretation in breast cancer. Population-matched and complete T2T reference genomes can reduce mapping ambiguity and improve the resolution of transcriptomic features, highlighting reference genome choice as an important and underappreciated source of systematic bias in cancer transcriptomics.

  • Open Access

    Approaching an error-free diploid human genome using a support-based validation framework

    by Yanan Chu, Zhuo Huang, Changjun Shao, Shuming Guo, Yiji Yang, Xinyao Yu, Yurong Luo, Jian Wang, Yabin Tian, Jing Chen, et al.


  • Open Access

    Enhancing Variant Calling in Whole-exome Sequencing Data Using Population-matched Reference Genomes

    by Shuming Guo, Zhuo Huang, Yanming Zhang, Yukun He, Xiangju Chen, Wenjuan Wang, Lansheng Li, Yu Kang, Zhancheng Gao, Jun Yu, et al.

    Whole-exome sequencing (WES) data are frequently used for cancer diagnosis and genome-wide association studies (GWAS), based on high-coverage read mapping, informative variant calling, and high-quality reference genomes. The center position of the currently used genome assembly, GRCh38, is now challenged by two newly published telomere-to-telomere (T2T) genomes, T2T-CHM13 and T2T-YAO, and it becomes urgent to have a comparative study to test population specificity using the three reference genomes based on real case WES data. Here, we report our analysis along this line for 19 tumor samples collected from Chinese patients. The primary comparison of the exon regions among the three references reveals that the sequences in up to ∼ 1% of target regions in T2T-YAO are widely diversified from GRCh38 and may lead to off-target in sequence capture. However, T2T-YAO still outperforms GRCh38 by obtaining 7.41% of more mapped reads. Due to more reliable read-mapping and closer phylogenetic relationship with the samples than GRCh38, T2T-YAO reduces half of variant calls of clinical significance which are mostly benign, while maintaining sensitivity in identifying pathogenic variants. T2T-YAO also outperforms T2T-CHM13 in reducing calls of Chinese-specific variants. Our findings highlight the critical need for employing population-specific reference genomes in genomic analysis to ensure accurate variant analysis and the significant benefits of tailoring these approaches to the unique genetic background of each ethnic group.


  • Open Access

    Enhancing Variant Calling in Whole Exome Sequencing (WES) Data Using Population-Matched Reference Genomes

    by Shuming Guo, Zhuo Huang, Yanming Zhang, Yukun He, Xiangju Chen, Wenjuan Wang, Lansheng Li, Yu Kang, Zhancheng Gao, Jun Yu, et al.

    Whole exon sequencing (WES) data are frequently used for cancer diagnosis and genome-wide association studies (GWAS), hinging upon high-coverage read mapping, informative variant calling, and high-quality reference genomes. The center position of the currently used genome assembly, GRCh38, is now challenged by two newly publicized telomere-to-telomere or T2T genomes, T2T-CHM13 and T2T-YAO, and it becomes urgent to have a comparative study to test population specificity using the three reference genomes based on real case WES data. We here report our analysis along this line for 19 tumor samples collected from Chinese patients. The primary comparison of the exon regions among the three references reveals that the sequences in up to ∼1% target regions in YAO are widely diversified from GRCh38 and may lead to off-target in sequence capture. However, YAO still outperforms GRCh38 genomes by obtaining 7.41% more mapped reads. Due to more reliable read-mapping and closer phylogenetic relationship with the samples than GRCh38, YAO reduces half of variant calls of clinical significance which are mostly benign while keeping sensitivity in identifying pathogenic variants. YAO also outperforms CHM13 in reducing calls of Chinese-specific variants. Our findings highlight the critical need for employing population-specific reference genomes in genomic analysis to ensure accurate variant analysis and the significant benefits of tailoring these approaches to the unique genetic backgrounds of each ethnic group.